Tissium (FR)

https://www.tissium.com

Twitter: @tissiumtech

LinkedIn: https://www.linkedin.com/company/tissium

TISSIUM is a privately-owned life sciences company based in Paris, France that is dedicated to the rapid development and commercialization of a unique biopolymer platform to address various unmet clinical needs. The company’s platform is based on a proprietary polymer family with unique properties including the ability to conform to, and integrate with, surrounding tissue to enable natural healing. Furthermore, the modular design of the polymers enables customization to match tissue-specific requirements for different therapeutic areas. The company also develops delivery and activation devices for enhanced performance and usability of its family of polymers. The Company’s technology is based on world-class research and intellectual property from the laboratories of Professor Robert Langer (MIT) and Professor Jeffrey M. Karp (Brigham and Women’s Hospital), who co-founded the company in 2013. *

	Start	2019-05-14 renamed
	Group	Tissium (Group)
	Predecessor	Gecko Biomedical (FR)
	Industry	tissues
	Industry 2	polymers
	Person	Bancel, Christophe (Gecko Biomedical 201603 CEO + Co-Founder)

	Region	Paris
	Country	France
	Street	74 rue du Faubourg Saint-Antoine
	City	75012 Paris
	Tel	+33-1-7621-7220
		Address record changed: 2021-01-29

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½: Tissium. (11/20/19). "Press Release: Tissium Closes €39M Series B Funding Round". Paris.

		Record changed: 2020-08-04